DRKS00026642Enrolling By Invitation不适用
Treatment of patients with immune-related adverse events after checkpoint inhibitors with extracorporeal photopheresis (ECP): a retrospective analysis and translational studies
适应症
试验速览
- 阶段
- 不适用
- 状态
- Enrolling By Invitation
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •age 18 years or older
- •written informed consent
- •previous Treatment with anti-PD-1, anti-PD-L1 or anti-CTLA4 antibodies
- •development of irAE after treatment with immune checkpoint inhibitors
- •treatment of irAE with ECP
排除标准
- •previous treatment with ECP in the medical history
研究者
相似试验
尚未招募
Unknown
Study the Methods for treating and boosting the immune system in diabetic foot ulcer patients.CTRI/2024/02/063190Dr D Y Patil Vidyapeeth
进行中（未招募）
1 期
Complex immunomodulatory therapy for patients with immune thrombocytopenia (T-MEM)Immune thrombocytopeniaMedDRA version: 23.0Level: PTClassification code: 10083842Term: Immune thrombocytopenia Class: 100000004851CTIS2023-505788-35-00Fakultni Nemocnice Hradec Kralove73
已完成
1 期
A combination immunotherapy for the patients with advanced or metastatic solid cancersolid cancerJPRN-UMIN000020440Yamaguchi university Graduate School of Medicine17
终止
不适用
A clinical trial to evaluate the effect of Losartan in early IgA nephropathy patientsDiseases of the genitourinary systemKCT0002916Ewha Womans University Medical Center174
进行中（未招募）
不适用
Supportive versus Immunosuppressive Therapy for the treatment Of Progressive IgA Nephropathy - STOP IgAEUCTR2007-000871-41-DERWTH Aachen148